Claims for Non-Detectable Defects. Myovant shall notify Takeda within [***] Business Days upon discovery of any defect in or failure of the Drug Substance to comply with Section 5.1 or Section 7.1 hereof that is not a Detectable Defect. Claims that are submitted by Myovant shall state the nature of the alleged defect, including how such alleged defect was discovered, in detail reasonably sufficient to enable Takeda to identify the nature of the alleged defect or to dispute the same, and to determine that the defect existed at the time of delivery.
Appears in 3 contracts
Samples: Commercial Manufacturing & Supply Agreement (Myovant Sciences Ltd.), Commercial Manufacturing & Supply Agreement (Myovant Sciences Ltd.), Commercial Manufacturing & Supply Agreement (Myovant Sciences Ltd.)
Claims for Non-Detectable Defects. Myovant shall notify Takeda within [***] Business Days upon discovery of any defect in or failure of the Drug Substance or Drug Product to comply with Section 5.1 4.1 or Section 7.1 hereof 6.1 that is not a Detectable Defect. Claims that are submitted by Myovant shall state the nature of the alleged defect, including how such alleged defect was discovered, in detail reasonably sufficient to enable Takeda to identify the nature of the alleged defect or to dispute the same, and to determine that the defect existed at the time of delivery.
Appears in 3 contracts
Samples: Manufacturing Agreement (Myovant Sciences Ltd.), Manufacturing Agreement (Myovant Sciences Ltd.), Manufacturing Agreement (Myovant Sciences Ltd.)